Futura Medical plc (LON:FUM – Get Free Report) shares dropped 12.7% during trading on Wednesday . The stock traded as low as GBX 9.75 ($0.13) and last traded at GBX 10 ($0.13). Approximately 1,345,431 shares were traded during trading, an increase of 81% from the average daily volume of 744,808 shares. The stock had previously closed at GBX 11.45 ($0.15).
Futura Medical Stock Performance
The firm has a fifty day moving average price of GBX 19.21 and a 200 day moving average price of GBX 29.19. The stock has a market cap of £31.17 million, a PE ratio of -8.25 and a beta of 1.25.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Further Reading
- Five stocks we like better than Futura Medical
- Breakout Stocks: What They Are and How to Identify Them
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- With Risk Tolerance, One Size Does Not Fit All
- 3 Must-Own Stocks to Build Wealth This Decade
- What Do S&P 500 Stocks Tell Investors About the Market?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
